novo nordisk ozempic - Search News

News

Hims, Novo Nordisk

Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent mandate. Hims pushed back against the accusation.

CBS News on MSN · 1d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Bloomberg on MSN · 13h

Novo exits Hims & Hers partnership, citing ‘deceptive marketing’ concerns

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is using “deceptive marketing” to sell copycat versions of its obesity blockbuster Wegovy.

Novo Nordisk launches weight-loss drug Wegovy

Barron's on MSN · 1d

Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.

Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled as the results missed investors’ expectations and reignited concerns about Novo’s rivalry with Eli Lilly.

Insider Monkey on MSN · 10h

Amgen (AMGN) Falls 5.8% as Novo Nordisk Hammers Its Weight Loss Drug Trial

Amgen Inc. (NASDAQ:AMGN) is one of the These 10 Stocks Took A Shocking Fall. Amgen Inc. extended its losing streak to a fourth straight day on Monday, dropping 5.84 percent to close at $272.44 apiece as investors sold off positions despite positive results from its weight loss drug trial,

Novo Nordisk preparing to launch weight-loss drug Wegovy in India

Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes that its position as a market leader for insulin products in the country could give it an edge.

1don MSN

EU drugs regulator to allow Novo Nordisk to include heart condition in Ozempic label

Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...

Ozempic maker announces not one, but three new weight-loss drugs

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

1don MSN

Novo Nordisk ends collaboration with Hims & Hers

Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap ...

Deccan Chronicle18h

Novo Nordisk Launches Anti-obesity Drug Wegovy in India

The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...

24/7 Wall St.4d

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

8don MSN

The story of how Novo Nordisk will lose billions because it didn’t pay a couple of hundred dollars

Novo Nordisk’s annual report contains an interesting footnote on its key drug, Ozempic, which last year accounted for $19 ...

4don MSN

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

Futurism on MSN5d

Something Comically Bad Just Happened to the Inventor of Ozempic

Novo Nordisk, the Danish pharma company behind Ozempic, made a very dumb decision a few years ago that will massively eat ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results